drugset / Trial / NCT01076790

Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli

NCT01076790 ↗

Phase 4 Completed 44 enrolled Arvi Yli-Hankala
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Dexmedetomidine acts at central nervous system (specifically: at locus caeruleus), providing sedative and analgesic effects. It is widely used in intensive care. Surgery-related interventions elicit arousal ('nociceptive') reactions. The effects of dexmedetomidine on the neurophysiological signs of arousal are studied in surgical patients. Brain waves, electrocardiogram, Entropy Index, Bispectral Index, and fingertip pulse waves are recorded and analyzed later on. The course of anaesthesia and surgery are recorded.

Timeline

Start
2009-11
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg —

Indications

No indication recorded.